Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Unfractionated heparin

High-Molecular-Weight Heparin (Unfractionated Heparin)... [Pg.1225]

Trials of Unfractionated Heparin Compared to LMWH and Heparinoids... [Pg.141]

Sandercock P, Counsell C, Stobbs SL. Low-molecular-weight heparins or Heparinoids versus standard Unfractionated heparin for acute ischemic stroke (Review). The Cochrane Collaboration 2006. [Pg.158]

All patients with a mechanical prosthetic heart valve should receive concomitant unfractionated heparin or a low molecular weight heparin in combination with warfarin pharmacotherapy until the INR is therapeutic and stable for two consecutive days... [Pg.42]

Formulate a monitoring plan for a patient with ST-segment elevation acute coronary syndrome receiving fibrinolytics, aspirin, unfractionated heparin, intravenous nitroglycerin, intravenous (3-blockers followed by oral P-blockers, an angiotensin-converting enzyme inhibitor, and a statin. [Pg.83]

Unfractionated heparin Bleeding, heparin-induced thrombocytopenia Clinical signs of bleeding3 baseline CBC and platelet count aPTT every 6 hours until target then every 24 hours daily CBC platelet count every 2 days (minimum, preferably every day)... [Pg.103]

State at least two potential advantages of the low-molecular-weight heparins and fondaparinux over unfractionated heparin. [Pg.133]

The most extensively studied drugs for the prevention of VTE are unfractionated heparin (UFH), the low-molecular-weight heparins (LMWHs dalteparin, enoxaparin, and tinza-parin), fondaparinux, and warfarin.2 The LMWHs and fondaparinux provide superior protection against VTE when... [Pg.141]

FIGURE 7-5. Treatment approach for patients with VTE. INR, International Normalized Ratio IV, intravenous LMWH, low-molecular-weight heparin PO, oral SC, subcutaneous UFH, unfractionated heparin VTE, venous thromboembolism. (Adapted from Nutescu EA. Emerging options in the treatment of venous thromboembolism. Am J Health Syst Pharm 2004 61 (Suppl 7) S16, with permission.)... [Pg.142]

Unfractionated heparin should not be used during thrombolytic therapy. Neither the aPTT nor any other anticoagulation parameter should be monitored during the thrombolytic infusion... [Pg.143]

If aPTT less than 2.5 times the control value, unfractionated heparin infusion should be started and adjusted to maintain aPTT in therapeutic range... [Pg.143]

See other pages where Unfractionated heparin is mentioned: [Pg.256]    [Pg.149]    [Pg.1223]    [Pg.256]    [Pg.149]    [Pg.1223]    [Pg.107]    [Pg.108]    [Pg.417]    [Pg.419]    [Pg.137]    [Pg.137]    [Pg.138]    [Pg.167]    [Pg.22]    [Pg.24]    [Pg.25]    [Pg.29]    [Pg.41]    [Pg.41]    [Pg.41]    [Pg.49]    [Pg.54]    [Pg.97]    [Pg.51]    [Pg.84]    [Pg.90]    [Pg.96]    [Pg.98]    [Pg.105]    [Pg.119]    [Pg.133]    [Pg.140]    [Pg.141]    [Pg.142]    [Pg.143]    [Pg.144]    [Pg.144]   
See also in sourсe #XX -- [ Pg.29 , Pg.31 ]

See also in sourсe #XX -- [ Pg.184 ]

See also in sourсe #XX -- [ Pg.154 , Pg.155 , Pg.156 , Pg.157 , Pg.158 , Pg.159 , Pg.169 ]



SEARCH



© 2024 chempedia.info